PBH
Prestige Consumer Healthcare Inc. · Healthcare · Medical - Pharmaceuticals
Momentum inputs (comparable managers):
holder breadth +5.6% ·
share flow -1.6% ·
net new positions 0.0%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 16.77K | $457,446 | n/a | n/a |
| Q2 2026 | 100 | -6 | 34.03M | $1.61B | +5 | −12 |
| Q1 2026 | 110 | -5 | 35.15M | $2.08B | +6 | −12 |
| Q4 2025 | 116 | -2 | 39.06M | $2.41B | +1 | −2 |
| Q3 2025 | 19 | +1 | 21.74M | $1.36B | +2 | −2 |
| Q2 2025 | 16 | 0 | 19.92M | $1.59B | +1 | −1 |
| Q1 2025 | 13 | 0 | 5.41M | $464.71M | n/a | n/a |
| Q4 2024 | 13 | -1 | 5.31M | $414.35M | n/a | −1 |
| Q3 2024 | 13 | 0 | 3.46M | $249.12M | +1 | −1 |
| Q2 2024 | 13 | n/a | 3.54M | $243.72M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 7.59M | -4.7% | $473.82M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (passive) | 5.49M | -2.5% | $342.75M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 1.96M | -1.7% | $122.60M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.44M | +1.7% | $89.71M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Morgan Stanley ✦ | 1.13M | n/a | $70.63M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 6 | JPMorgan Chase ✦ | 918.46K | n/a | $57.31M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 7 | Fidelity (FMR) ✦ | 733.50K | -1.6% | $45.77M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 8 | Goldman Sachs Group ✦ | 639.81K | n/a | $39.92M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 9 | T. Rowe Price ✦ | 547.87K | +3.1% | $34.19M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | D. E. Shaw & Co. ✦ | 538.02K | +87.7% | $33.57M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Fisher Asset Management ✦ | 293.71K | -3.9% | $18.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 229.20K | -43.5% | $14.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 63.53K | +187.3% | $3.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 46.51K | New | $2.90M | 0.0% | New | 1 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 36.70K | +210.2% | $2.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 24.12K | +14.7% | $1.49M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 17 | Wellington Management ✦ | 21.64K | +6.0% | $1.35M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 18 | Millennium Management ✦ | 18.03K | -30.0% | $1.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 9.66K | New | $602,597 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $2.90M | 0.0% |
| Bridgewater Associates | $602,597 | 0.0% |
Exited
| Norges Bank | $41.85M | was 0.0% |
| Two Sigma Investments | $524,375 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 350 holders, 51.73M shares, $2.97B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.